Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TriSalus Life Sciences, Inc.TLSI · Entity 5872 | Chief Financial Officer | May 19, 2025 | May 21, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TriSalus Life Sciences, Inc.
Report date May 19, 2025 · Filed May 21, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 49,663 |
Reported balance
After 2025-05-19 transaction · row 1
1 source rowRow 1 · 2025-05-19 · Grant · Acquired 13,175 · Balance 49,663 F1: The granted RSUs vest immediately. |
| Common StockSEC Table I · non-derivative | IndirectBy Kathleen A. Young Living Trust | 30,000 |
Reported balance
Holding disclosure · report date 2025-05-19 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 30,000 F2: The Reporting Person is the sole trustee of Kathleen A. Young Living Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: The granted RSUs vest immediately.
F2: The Reporting Person is the sole trustee of Kathleen A. Young Living Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2025 Filed May 21, 2025 17:37 UTC | TriSalus Life Sciences, Inc. TLSI · Entity 5872 | GrantCommon Stock | 13,175 | $5.18 | $68,246.50 |
DisclosureSEC source: 0001826667-25-000063 · wk-form4_1747863414.xml · nonDerivative · entry 1 Young James Emmett · CIK 0002050748 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,663 F1 · shares: The granted RSUs vest immediately. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 17:49 UTC | TriSalus Life Sciences, Inc. TLSI · Entity 5872 | GrantCommon Stock | 14,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-004688 · form4-02192025_100242.xml · nonDerivative · entry 1 Young James Emmett · CIK 0002050748 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,488 F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. 12.5% of the shares subject to the RSU Award shall vest on the grant date of February 18, 2025; 25% of the shares subject to the RSU Award shall vest on each of May 15, 2025, August 15, 2025, and November 14, 2025; and the remaining shares subject to the RSU Award will vest on February 13, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. Read SEC document |
| February 05, 2025 Filed Feb 6, 2025 18:09 UTC | TriSalus Life Sciences, Inc. TLSI · Entity 5872 | PurchaseCommon Stock | 6,000 | $5.65 | $33,900.00 |
DisclosureSEC source: 0001415889-25-003293 · form4-02062025_110257.xml · nonDerivative · entry 1 Young James Emmett · CIK 0002050748 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Kathleen A. Young Living Trust Disclosed balance after: 30,000 F1 · ownership.nature: The Reporting Person is the sole trustee of Kathleen A. Young Living Trust. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 18:03 UTC | TriSalus Life Sciences, Inc. TLSI · Entity 5872 | GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $5.30 | $0.00 |
DisclosureSEC source: 0001415889-25-002287 · form4-01292025_110141.xml · derivative · entry 3 Young James Emmett · CIK 0002050748 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2035-01-26 F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 18:03 UTC | TriSalus Life Sciences, Inc. TLSI · Entity 5872 | PurchaseCommon Stock | 24,000 | $5.40 | $129,600.00 |
DisclosureSEC source: 0001415889-25-002287 · form4-01292025_110141.xml · nonDerivative · entry 2 Young James Emmett · CIK 0002050748 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Kathleen A. Young Living Trust Disclosed balance after: 24,000 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.11 to $5.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: The Reporting Person is the sole trustee of Kathleen A. Young Living Trust. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 18:03 UTC | TriSalus Life Sciences, Inc. TLSI · Entity 5872 | GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002287 · form4-01292025_110141.xml · nonDerivative · entry 1 Young James Emmett · CIK 0002050748 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,726 F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.